Article Details
Retrieved on: 2025-09-19 17:43:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The CHMP's endorsement, issued on September 19, 2025, positions nipocalimab as a groundbreaking FcRn-blocking monoclonal antibody for the treatment of ...
Article found on: www.ainvest.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here